OCS Liver PROTECT Continued Access Protocol

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

February 2, 2021

Study Completion Date

February 2, 2023

Conditions
Liver Transplant
Interventions
DEVICE

OCS Liver System

OCS Liver System for preserving and assessing donor livers for transplantation

Trial Locations (17)

10029

Mount Sinai Hospital, New York

10467

Montefiore Einstein Center for Transplantation, The Bronx

21205

Johns Hopkins, Baltimore

22903

University of Virginia, Charlottesville

23298

Virginia Commonwealth University Health System, Richmond

33606

Tampa General, Tampa

38104

Methodist University Hospital, Memphis

43210

Ohio State University, Columbus

48202

Henry Ford Hospital, Detroit

68198

University of Nebraska Medical Center, Omaha

75390

University of Texas Southwest, Dallas

77030

Houston Methodist Hospital, Houston

78229

The University of Texas Health Science Center at San Antonio, San Antonio

92037

Scripps, La Jolla

University of California San Diego, La Jolla

94143

UCSF, San Francisco

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT04186221 - OCS Liver PROTECT Continued Access Protocol | Biotech Hunter | Biotech Hunter